Clinical Evaluation of Bulk-fill Alkasite Restoration Versus Resin Modified Glass Ionomer in Adult With Class V Carious
1 other identifier
interventional
28
0 countries
N/A
Brief Summary
Cention N will have the same clinical performance as resin-modified glass ionomer in cervical carious lesions. Evaluation of restorations will be done at baseline, six months, and one year according (USPHS) criteria.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2021
CompletedFirst Posted
Study publicly available on registry
January 20, 2021
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedJuly 28, 2021
July 1, 2021
1 year
January 11, 2021
July 27, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
(Marginal adaptation)
(USPHS) criteria
12 months
Secondary Outcomes (1)
Clinical performance (Anatomical form, Secondary caries, marginal discoloration, Postoperative sensitivity, Color match, Retention)
12 months
Study Arms (2)
Cention N
EXPERIMENTALIntervention Alkasite Restoration will be used to restore cervical carious in adult patients.
Resin Modified Glass Ionomer
ACTIVE COMPARATORComparator Resin-modified glass ionomer material will be used to restore cervical carious in adult patients.
Interventions
Alkasite restorative is a category of filling material, like compomer, and is essentially a subgroup of the composite resin. Cention N is a urethane dimethacrylate (UDMA)-based, self-curing powder/liquid restorative with optional additional light curing. The liquid comprises of dimethacrylates and initiators, while the powder contains various glass fillers, initiators, and pigments. It is radio opaque and contains alkaline glass fillers capable of releasing fluoride, calcium, and hydroxide ions. Due to the sole use of cross-linking methacrylate monomers in combination with a stable, efficient self-cure initiator, Cention N displays a high polymer network density and degree of polymerization over the complete depth of the restoration.
The resin-modified glass ionomer materials are hybrid materials of traditional glass ionomer cement with a small addition of light-curing resin, and hence exhibit properties intermediate to the two, with some characteristics superior to conventional glass ionomer materials
Eligibility Criteria
You may qualify if:
- Patients with High caries risk.
- Patients with poor oral hygiene.
- Patients with untreated cervical caries lesion.
- patient aging ≥18 years.
- Absence of tooth mobility
- Absence of abnormal occlusion.
- Patients with good likelihood of recall availability.
You may not qualify if:
- Patients with cervical caries lesions need crown restoration.
- Non-vital teeth.
- Evidence of parafunctional habits.
- Teeth supporting removable prosthesis.
- Periapical Abscess or Fistula.
- Patients with systemic disease.
- Patients with xerostomia.
- Participants with a history of allergy to any component of restorations will be used in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Related Publications (1)
Al-Salamony H, Akah M, Naguib EA, Safwat OM. Clinical Evaluation of Bulk-fill Alkasite Restoration vs Resin-modified Glass Ionomer in Class V Carious Lesions: 1-year Randomized Clinical Trial. J Contemp Dent Pract. 2024 Dec 1;25(12):1127-1134. doi: 10.5005/jp-journals-10024-3787.
PMID: 40079991DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle investigator
Study Record Dates
First Submitted
January 11, 2021
First Posted
January 20, 2021
Study Start
November 1, 2021
Primary Completion
November 1, 2022
Study Completion
December 1, 2022
Last Updated
July 28, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Expecting to have all the data by October 2022